Plasma DNA integrity indicates response to neoadjuvant chemotherapy in patients with locally confined breast cancer

MeSH terms

• Antineoplastic Agents / blood
• Antineoplastic Agents / therapeutic use*
• Biomarkers, Tumor / blood*
• Breast Neoplasms / blood*
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / surgery
• Carcinoma, Ductal, Breast / blood
• Carcinoma, Ductal, Breast / drug therapy
• Carcinoma, Ductal, Breast / surgery
• Carcinoma, Lobular / blood
• Carcinoma, Lobular / drug therapy
• Carcinoma, Lobular / surgery
• Cyclophosphamide / blood
• Cyclophosphamide / therapeutic use
• DNA / blood*
• Docetaxel
• Epirubicin / blood
• Epirubicin / therapeutic use
• Female
• Follow-Up Studies
• Humans
• Neoadjuvant Therapy / methods*
• Taxoids / blood
• Taxoids / therapeutic use
• Treatment Outcome